All lobbying clients
FERRING PHARMACEUTICALS, INC.
Lobbying client · New Jersey · filed 2025 to 2026
A privately-held biopharmaceutical company.
$2,900,000
Reported spend
37
Filings counted
5
Outside firms hired
13
Bills named
Who filed for this client
6
- FERRING PHARMACEUTICALS, INC. $1,500,000
- BAKER & HOSTETLER LLP $420,000
- BALLARD PARTNERS $400,000
- BROWNSTEIN HYATT FARBER SCHRECK, LLP $380,000
- TODD STRATEGY GROUP $200,000
- HILLSTAFFER, LLC $0
Bills named in these filings
13
Reported by year
2 years
- 2026 $1,390,000
- 2025 $1,510,000
Issues lobbied
5
Agencies and chambers lobbied
8
- HOUSE OF REPRESENTATIVES
- SENATE
- Commerce, Dept of (DOC)
- Executive Office of the President (EOP)
- Health & Human Services, Dept of (HHS)
- U.S. Trade Representative (USTR)
- White House Office
- Bureau of Industry and Security (BIS)
Recent filings
38 total
Q3 reportNo activity
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q2 reportNo activity
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q1 reportNo activity
View →
Q4 termination
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
Q4 reportNo activity
View →
Q4 report
View →
Q4 report
View →
Q4 report
View →
HILLSTAFFER, LLC
FERRING PHARMACEUTICALS, INC.
BAKER & HOSTETLER LLP
BROWNSTEIN HYATT FARBER SCHRECK, LLP
BALLARD PARTNERS
HILLSTAFFER, LLC
BROWNSTEIN HYATT FARBER SCHRECK, LLP
FERRING PHARMACEUTICALS, INC.
BAKER & HOSTETLER LLP
BALLARD PARTNERS
HILLSTAFFER, LLC
TODD STRATEGY GROUP
BAKER & HOSTETLER LLP
BROWNSTEIN HYATT FARBER SCHRECK, LLP
FERRING PHARMACEUTICALS, INC.
BALLARD PARTNERS
HILLSTAFFER, LLC
TODD STRATEGY GROUP
Amended
BROWNSTEIN HYATT FARBER SCHRECK, LLP
BAKER & HOSTETLER LLP
Foreign entities disclosed
1
- FERRING HOLDING SA